...
首页> 外文期刊>Chemosphere >Identification of miRNA-7 as a regulator of brain-derived neurotrophic factor/α-synuclein axis in atrazine-induced Parkinson's disease by peripheral blood and brain microRNA profiling
【24h】

Identification of miRNA-7 as a regulator of brain-derived neurotrophic factor/α-synuclein axis in atrazine-induced Parkinson's disease by peripheral blood and brain microRNA profiling

机译:通过外周血和大脑microRNA谱鉴定miRNA-7作为阿特拉津诱导的帕金森氏病脑源性神经营养因子/α-突触核蛋白轴的调节剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine; ATR) is widely used as an herbicide, and its accumulation in the environment is a health risk to humans; for instance, it has been shown to cause dopaminergic neurotoxicity. MicroRNAs (miRNAs) are endogenous small RNA5 that regulate gene expression in diverse physiological contexts; however, the extent of their involvement in the development of Parkinson's disease (PD) is not known. In this study, we carried out miRNA profiling of peripheral blood and brain tissue in a rat model of PD in order to identify factors that mediate PD pathogenesis. The miRNAmiR-7 is known to cause the downregulation of alpha-synuclein (alpha-syn), which is linked to the neuropathology of PD. Here we found that miR-7 was upregulated in brain tissue but downregulated in peripheral blood of rats with ATR-induced PD. We also found that miR-7 regulates the expression of brain-derived neurotrophic factor (BDNF) through an auto regulatory mechanism. These findings indicate that miRNA-7 regulates the BDNF/alpha-syn axis in the early stages of PD and can serve as a biomarker or therapeutic target for disease treatment. (C) 2019 Elsevier Ltd. All rights reserved.
机译:阿特拉津(2-氯-4-乙基氨基-6-异丙基氨基-s-三嗪; ATR)被广泛用作除草剂,其在环境中的积累对人类健康构成威胁;例如,已经证明它会引起多巴胺能神经毒性。微小RNA(miRNA)是内源性小RNA5,可在多种生理环境中调节基因表达。但是,他们参与帕金森氏病(PD)的发展程度尚不清楚。在这项研究中,我们在PD大鼠模型中进行了外周血和脑组织的miRNA分析,以鉴定介导PD发病机理的因素。已知miRNAmiR-7会导致α-突触核蛋白(α-syn)的下调,这与PD的神经病理学有关。在这里,我们发现miR-7在ATR诱导的PD大鼠的脑组织中上调,但在外周血中下调。我们还发现,miR-7通过自动调节机制调节脑源性神经营养因子(BDNF)的表达。这些发现表明,miRNA-7在PD的早期阶段调节BDNF /α-syn轴,可以作为疾病治疗的生物标志物或治疗靶标。 (C)2019 Elsevier Ltd.保留所有权利。

著录项

  • 来源
    《Chemosphere》 |2019年第10期|542-548|共7页
  • 作者单位

    Harbin Med Univ, Harbin, Heilongjiang, Peoples R China;

    Harbin Med Univ, Harbin, Heilongjiang, Peoples R China;

    Harbin Med Univ, Harbin, Heilongjiang, Peoples R China;

    Harbin Med Univ, Harbin, Heilongjiang, Peoples R China;

    Harbin Med Univ, Harbin, Heilongjiang, Peoples R China;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Atrazine; microRNA; BDNF; Parkinson'Disease;

    机译:阿特拉津;微小RNA;BDNF;帕金森病;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号